多发性-话题@MedSci

#多发性#

905篇内容 | 3324人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890031, encodeId=f18d1890031cc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019年欧洲神经病学学会（EAN）：CD20单抗Ublituximab治疗复发多发性硬化患者安全、耐受良好, objectType=article, longId=174977, objectId=d4a81e497768, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4a81e497768, replyNumber=0, likeNumber=69, createdTime=2019-10-29, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4a81e497768, moduleTitle=2019年欧洲神经病学学会（EAN）：CD20单抗Ublituximab治疗复发多发性硬化患者安全、耐受良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4a81e497768)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890037, encodeId=0e15189003e93, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=强生向FDA提交申请寻求批准其抗CD38单抗DARZALEX皮下制剂治疗多发性骨髓瘤, objectType=article, longId=175459, objectId=e3f31e5459bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3f31e5459bb, replyNumber=0, likeNumber=69, createdTime=2019-08-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3f31e5459bb, moduleTitle=强生向FDA提交申请寻求批准其抗CD38单抗DARZALEX皮下制剂治疗多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3f31e5459bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890041, encodeId=79a8189004123, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA-Neurol：儿童肥胖会增加多发性硬化发生的风险, objectType=article, longId=176152, objectId=8a2f1e615272, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a2f1e615272, replyNumber=0, likeNumber=114, createdTime=2020-05-06, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a2f1e615272, moduleTitle=JAMA-Neurol：儿童肥胖会增加多发性硬化发生的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a2f1e615272)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890005, encodeId=f851189000552, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症, objectType=article, longId=165885, objectId=92ae165885e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92ae165885e9, replyNumber=0, likeNumber=79, createdTime=2019-11-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92ae165885e9, moduleTitle=罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92ae165885e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890039, encodeId=94c018900390a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性骨髓瘤患者腰椎间盘突出重吸收1例, objectType=article, longId=175705, objectId=27f41e57050a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27f41e57050a, replyNumber=0, likeNumber=69, createdTime=2020-06-22, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27f41e57050a, moduleTitle=多发性骨髓瘤患者腰椎间盘突出重吸收1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27f41e57050a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890046, encodeId=b9521890046bd, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Nature：多发性硬化症患者大脑的疾病根源——投射神经元, objectType=article, longId=177182, objectId=6ca51e7182eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ca51e7182eb, replyNumber=0, likeNumber=65, createdTime=2020-01-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca51e7182eb, moduleTitle=Nature：多发性硬化症患者大脑的疾病根源——投射神经元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ca51e7182eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890054, encodeId=6d841890054fe, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定, objectType=article, longId=178782, objectId=c6a71e8782a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6a71e8782a5, replyNumber=0, likeNumber=99, createdTime=2020-02-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6a71e8782a5, moduleTitle=CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6a71e8782a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890017, encodeId=3c0a189001ed1, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet：Daratumumab联合标准治疗方案治疗新发多发性骨髓瘤, objectType=article, longId=167672, objectId=ca1516e672e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1516e672e7, replyNumber=0, likeNumber=81, createdTime=2020-05-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1516e672e7, moduleTitle=Lancet：Daratumumab联合标准治疗方案治疗新发多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca1516e672e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890081, encodeId=09ee189008189, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=葛兰素史克的靶向BCMA抗体偶联药物在多发性骨髓瘤研究中总缓解率达31％, objectType=article, longId=184903, objectId=60b518490392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60b518490392, replyNumber=0, likeNumber=70, createdTime=2020-07-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60b518490392, moduleTitle=葛兰素史克的靶向BCMA抗体偶联药物在多发性骨髓瘤研究中总缓解率达31％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60b518490392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890056, encodeId=09f8189005665, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性骨髓瘤中西医结合诊疗专家共识（2019）, objectType=article, longId=179171, objectId=75a61e9171b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75a61e9171b4, replyNumber=0, likeNumber=58, createdTime=2020-04-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75a61e9171b4, moduleTitle=多发性骨髓瘤中西医结合诊疗专家共识（2019）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75a61e9171b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890086, encodeId=14a9189008645, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019 循证建议：多发性神经病电诊断检查和诊断策略, objectType=article, longId=185911, objectId=8afb18591156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8afb18591156, replyNumber=0, likeNumber=20, createdTime=2020-11-02, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8afb18591156, moduleTitle=2019 循证建议：多发性神经病电诊断检查和诊断策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8afb18591156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890077, encodeId=413218900e718, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=PNAS发文揭示治疗多发性骨髓瘤和三阴性乳腺癌的潜在药物靶点和候选药物分子, objectType=article, longId=184311, objectId=02b2184311ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b2184311ca, replyNumber=0, likeNumber=66, createdTime=2020-03-02, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b2184311ca, moduleTitle=PNAS发文揭示治疗多发性骨髓瘤和三阴性乳腺癌的潜在药物靶点和候选药物分子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02b2184311ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890048, encodeId=8bc318900482c, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=以腰腿痛为首发症状的多发性骨髓瘤, objectType=article, longId=177683, objectId=b95d1e7683c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b95d1e7683c1, replyNumber=0, likeNumber=62, createdTime=2019-10-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b95d1e7683c1, moduleTitle=以腰腿痛为首发症状的多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b95d1e7683c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890030, encodeId=ec16189003056, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：皮下注射达雷木单抗治疗复发性/难治性多发性骨髓瘤, objectType=article, longId=174848, objectId=d8fa1e484829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8fa1e484829, replyNumber=0, likeNumber=70, createdTime=2020-01-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8fa1e484829, moduleTitle=Blood：皮下注射达雷木单抗治疗复发性/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8fa1e484829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890070, encodeId=bc7118900e011, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=科济生物CAR-T细胞疗法治疗复发或难治性多发性骨髓瘤，被FDA授予再生医学先进疗法称号, objectType=article, longId=182335, objectId=990d182335ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990d182335ef, replyNumber=0, likeNumber=152, createdTime=2020-03-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990d182335ef, moduleTitle=科济生物CAR-T细胞疗法治疗复发或难治性多发性骨髓瘤，被FDA授予再生医学先进疗法称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990d182335ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890067, encodeId=e2a6189006e58, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Radiology：多发性硬化认知损害在功能MRI上的体现, objectType=article, longId=181049, objectId=e8be18104907, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8be18104907, replyNumber=0, likeNumber=75, createdTime=2020-05-15, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8be18104907, moduleTitle=Radiology：多发性硬化认知损害在功能MRI上的体现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8be18104907)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890090, encodeId=f0bc189009055, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA Surg：低剂量全身CT用于多发性创伤检查, objectType=article, longId=186598, objectId=3e02186598e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e02186598e5, replyNumber=0, likeNumber=82, createdTime=2020-12-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e02186598e5, moduleTitle=JAMA Surg：低剂量全身CT用于多发性创伤检查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e02186598e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889975, encodeId=2d4d18899e5eb, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：多发性骨髓瘤17p缺失的亚克隆比例越高，患者预后越差, objectType=article, longId=159620, objectId=014d159620e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=014d159620e4, replyNumber=0, likeNumber=81, createdTime=2019-09-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=014d159620e4, moduleTitle=Blood：多发性骨髓瘤17p缺失的亚克隆比例越高，患者预后越差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=014d159620e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890052, encodeId=30881890052ae, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Radiology：多发性硬化患者皮层病变在7.0T MRI上的进展及转归特点, objectType=article, longId=178489, objectId=05cc1e84896c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05cc1e84896c, replyNumber=0, likeNumber=74, createdTime=2020-06-07, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05cc1e84896c, moduleTitle=Radiology：多发性硬化患者皮层病变在7.0T MRI上的进展及转归特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05cc1e84896c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890034, encodeId=1004189003493, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=II期GRIFFIN研究结果：达雷妥尤单抗联合来那度胺、硼替佐米和地塞米松治疗初治多发性骨髓瘤, objectType=article, longId=175089, objectId=c27b1e5089d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c27b1e5089d0, replyNumber=0, likeNumber=0, createdTime=2020-02-02, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c27b1e5089d0, moduleTitle=II期GRIFFIN研究结果：达雷妥尤单抗联合来那度胺、硼替佐米和地塞米松治疗初治多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c27b1e5089d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019年欧洲神经病学学会（EAN）：CD20单抗Ublituximab治疗复发多发性硬化患者安全、耐受良好

2019-10-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

强生向FDA提交申请寻求批准其抗CD38单抗DARZALEX皮下制剂治疗多发性骨髓瘤

2019-08-30

heli0118 (审核中...)

前往app查看评论内容

#多发性#

JAMA-Neurol：儿童肥胖会增加多发性硬化发生的风险

2020-05-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症

2019-11-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性骨髓瘤患者腰椎间盘突出重吸收1例

2020-06-22

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Nature：多发性硬化症患者大脑的疾病根源——投射神经元

2020-01-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定

2020-02-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet：Daratumumab联合标准治疗方案治疗新发多发性骨髓瘤

2020-05-20

jml2009 (审核中...)

前往app查看评论内容

#多发性#

葛兰素史克的靶向BCMA抗体偶联药物在多发性骨髓瘤研究中总缓解率达31％

2020-07-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性骨髓瘤中西医结合诊疗专家共识（2019）

2020-04-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019 循证建议：多发性神经病电诊断检查和诊断策略

2020-11-02

jml2009 (审核中...)

前往app查看评论内容

#多发性#

PNAS发文揭示治疗多发性骨髓瘤和三阴性乳腺癌的潜在药物靶点和候选药物分子

2020-03-02

jml2009 (审核中...)

前往app查看评论内容

#多发性#

以腰腿痛为首发症状的多发性骨髓瘤

2019-10-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：皮下注射达雷木单抗治疗复发性/难治性多发性骨髓瘤

2020-01-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

科济生物CAR-T细胞疗法治疗复发或难治性多发性骨髓瘤，被FDA授予再生医学先进疗法称号

2020-03-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Radiology：多发性硬化认知损害在功能MRI上的体现

2020-05-15

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JAMA Surg：低剂量全身CT用于多发性创伤检查

2020-12-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：多发性骨髓瘤17p缺失的亚克隆比例越高，患者预后越差

2019-09-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Radiology：多发性硬化患者皮层病变在7.0T MRI上的进展及转归特点

2020-06-07

jml2009 (审核中...)

前往app查看评论内容

#多发性#

II期GRIFFIN研究结果：达雷妥尤单抗联合来那度胺、硼替佐米和地塞米松治疗初治多发性骨髓瘤

2020-02-02

科室
- - 订阅+
  - 更多科室
工具
服务